Diverse origins of the myofibroblast—implications for kidney fibrosis

LL Falke, S Gholizadeh, R Goldschmeding… - Nature Reviews …, 2015 - nature.com
Fibrosis is the common end point of chronic kidney disease. The persistent production of
inflammatory cytokines and growth factors leads to an ongoing process of extracellular …

The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV

N Hemmat, Z Asadzadeh, NK Ahangar… - Archives of …, 2021 - Springer
The number of descriptions of emerging viruses has grown at an unprecedented rate since
the beginning of the 21 st century. Severe acute respiratory syndrome coronavirus 2 (SARS …

Curcumin as a natural regulator of monocyte chemoattractant protein-1

MS Karimian, M Pirro, M Majeed, A Sahebkar - Cytokine & growth factor …, 2017 - Elsevier
Abstract Monocyte chemoattractant/chemotactic protein-1 (MCP-1), a member of the CC
chemokine family, is one of the key chemokines that regulate migration and tissue infiltration …

Mechanisms of renal apoptosis in health and disease

AB Sanz, B Santamari, M Ruiz-Ortega… - Journal of the …, 2008 - journals.lww.com
Apoptotic cell death is usually a response to the cell microenvironment. Apoptosis requires
the activation of lethal molecules and the inactivation of prosurvival ones. Both are potential …

Effects of selonsertib in patients with diabetic kidney disease

GM Chertow, PE Pergola, F Chen… - Journal of the …, 2019 - journals.lww.com
Background Apoptosis signal-regulating kinase 1 (ASK1) activation in glomerular and
tubular cells resulting from oxidative stress may drive kidney disease progression. Findings …

Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells

MEM Dolman, S Harmsen, G Storm… - Advanced drug delivery …, 2010 - Elsevier
Activated signaling cascades in the proximal tubular cells of the kidneys play a crucial role in
the development of tubulointerstitial fibrosis. Inhibition of these signaling cascades with …

Treatment targets in renal fibrosis

P Boor, K Šebeková, T Ostendorf… - Nephrology Dialysis …, 2007 - academic.oup.com
Renal fibrosis is the principal process underlying the progression of chronic kidney disease
(CKD) to endstage renal disease (ESRD). It is a relatively uniform response involving …

[PDF][PDF] Reduction of advanced liver fibrosis by short‐term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats

M Moreno, T Gonzalo, RJ Kok, P Sancho‐Bru… - …, 2010 - Wiley Online Library
There is no effective therapy for advanced liver fibrosis. Angiotensin type 1 (AT1) receptor
blockers attenuate liver fibrogenesis, yet their efficacy in reversing advanced fibrosis is …

Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells

I Altintas, R Heukers, R van der Meel… - Journal of Controlled …, 2013 - Elsevier
A novel, EGFR-targeted nanomedicine has been developed in the current study.
Glutaraldehyde crosslinked albumin nanoparticles with a size of approximately 100nm were …

ASK1 contributes to fibrosis and dysfunction in models of kidney disease

JT Liles, BK Corkey, GT Notte… - The Journal of …, 2018 - Am Soc Clin Investig
Oxidative stress is an underlying component of acute and chronic kidney disease. Apoptosis
signal–regulating kinase 1 (ASK1) is a widely expressed redox-sensitive serine threonine …